G protein beta 3(GNβ3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies
- PMID: 29416810
- PMCID: PMC5788678
- DOI: 10.18632/oncotarget.23449
G protein beta 3(GNβ3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies
Abstract
Several studies have reported an association between GNβ3 C825T polymorphism and irritable bowel syndrome (IBS). However, the results remain inconclusive and controversial, particularly for the data derived from different ethnicities and IBS subtypes. Therefore, we performed an updated meta-analysis to evaluate this association. All eligible case-control studies that met the search criteria were retrieved from multiple databases, and eleven case-control studies were included for detailed evaluation. The pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to assess the strengths of the association between GNβ3 C825T polymorphism and susceptibility to IBS and its subtypes. Our meta-analysis found no significantly associations of GNβ3 C825T polymorphism with IBS risk in all populations. Whereas the C allele was demonstrated to be a decreased risk factor for constipation predominant IBS (IBS-C) in allele model. Additionally, the CC genotype was found to be associated with increased diarrhea predominant IBS (IBS-D) risk in recessive model. Subgroup analysis by ethnicity revealed that these associations held true for the Asian subpopulation. In conclusion, this meta-analysis suggests the C allele of GNβ3 C825T might be associated with a decreased risk of IBS-C, and the CC genotype of GNβ3 might be associated with increased IBS-D risk.
Keywords: GNβ3; case-control; irritable bowel syndrome; meta-analysis; polymorphism.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Figures





Similar articles
-
HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis.Oncotarget. 2017 Jul 29;8(59):100459-100468. doi: 10.18632/oncotarget.19682. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245992 Free PMC article.
-
Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?Gastroenterology. 2006 Jun;130(7):1985-94. doi: 10.1053/j.gastro.2006.03.017. Gastroenterology. 2006. PMID: 16762621
-
The C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Depression: A Meta-Analysis.PLoS One. 2015 Jul 6;10(7):e0132274. doi: 10.1371/journal.pone.0132274. eCollection 2015. PLoS One. 2015. PMID: 26147511 Free PMC article.
-
Candidate single nucleotide polymorphisms of irritable bowel syndrome: a systemic review and meta-analysis.BMC Gastroenterol. 2019 Oct 15;19(1):165. doi: 10.1186/s12876-019-1084-z. BMC Gastroenterol. 2019. PMID: 31615448 Free PMC article.
-
The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.BMC Gastroenterol. 2014 Feb 10;14:23. doi: 10.1186/1471-230X-14-23. BMC Gastroenterol. 2014. PMID: 24512255 Free PMC article. Review.
Cited by
-
Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews.BMC Med. 2025 Feb 21;23(1):103. doi: 10.1186/s12916-025-03930-5. BMC Med. 2025. PMID: 39985070 Free PMC article.
-
Ethnic differences in genetic polymorphism associated with irritable bowel syndrome.World J Gastroenterol. 2020 May 7;26(17):2049-2063. doi: 10.3748/wjg.v26.i17.2049. World J Gastroenterol. 2020. PMID: 32536774 Free PMC article. Review.
References
-
- Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–58. https://doi.org/10.1001/jama.2015.0954. - DOI - PubMed
-
- Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, Hungin APS, Kang JY, Minhu C, Schmulson M, Bolotin A, Friger M, Freud T, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66:1075–82. https://doi.org/10.1136/gutjnl-2015-311240. - DOI - PubMed
-
- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90. https://doi.org/10.1053/j.gastro.2006.03.008. - DOI - PubMed
-
- Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–91. https://doi.org/10.1053/j.gastro.2005.11.061. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous